HCPCS Level IIdrugActive
J9311
Inj rituximab, hyaluronidase
BETOS: O1D
Effective: 2019-01-01
Referenced in 1 policies
Description
Injection, rituximab 10 mg and hyaluronidase
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rituxan Hycela
Manufacturer
Genentech, Inc.
HCPCS Dosage
10 MG (rituximab)
Billing Units
140.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.